As more therapies gain approval and demonstrate effectiveness, the coverage of stem cell therapy by insurance companies is expected to improve
N-Acetyl Cysteine (NAC), a precursor of glutathione, is therefore often used instead and has been shown to successfully raise plasma glutathione levels, for example, in those with schizophrenia.[xi] Anthocyandins also recycle glutathione thus sparing it if supplemented together.[xii] NAC has plenty of evidence to support its use as a promoter of glutathione and mental health, thus reducing the brains oxidative stress
Marked mydriasis rather than miosis may be seen with hypoxia in overdose situations [see CLINICAL PHARMACOLOGY]
The KLOW peptide blend is one of those combinations
However, significant data gaps remain regarding systemic absorption, multi-organ metabolism, long-term exposure, and potential liver-related risks